Planning to outsource manufacturing: Have you done your homework? | 7230
Journal of Developing Drugs

Journal of Developing Drugs
Open Access

ISSN: 2329-6631

+44 1478 350008

Planning to outsource manufacturing: Have you done your homework?

5th International Summit on GMP, GCP & Quality Control

August 12-13, 2016 Toronto, Canada

Mohammed R Khan

Synergex Consulting, Canada

Keynote: J Develop Drugs

Abstract :

Globally rising healthcare costs, downsizing of healthcare expenditures, expiring patents and genericization, are all affecting the profitability of pharmaceuticals and forcing companies to find more cost-efficient ways of developing the drugs as well as producing the products. Outsourcing thus emerges as a logical alternative when appropriate. Contractingout is not free of hurdles and challenges. Selecting the right contractor, confidentiality and intellectual property protection, ensuring an efficient two-way communication, Regulatory Compliance, keeping the client up-to-date on change controls, possible personality clashes between the client��?s and contractor��?s personnel, all manifest as bumps and hurdles. On the other hand, the overwhelming external marketing variables and the resultant loss of profitability are forcing the industry to critically look at the way it conducts its business and define profit-oriented operational strategies. Outsourcing thus emerges as a neat fit in the business design of the pharmaceutical industry of today and tomorrow, while partially or even totally freeing the business of the burden of capital investment and fixed cost issues, while also affording the advantage of reducing the time to market.

Biography :

Mohammed R Khan is a Quality Management Consultant and Principal Synergex Consulting in Ontario, Canada. He has earlier served as Director QA, QC & Regulatory Compliance with DuPont Pharmaceuticals, Canada, and on the Board of the Pharmaceutical Manufacturers Association of Canada, Plant Operations Section. He has also served on the DIA’s Advisory Council of North America and chaired the DIA’s Canadian Programming Steering Committee and is the recipient of the DIA Outstanding Service Award. He has served as Program Coordinator, Program Committee Member, Session Chair and Speaker at numerous national and international DIA events, as well as Presenter for the PDA, OMICS Group, IQPC, PSG Canada, UK based International Society of Ethnopharmacology, and the Indian Pharmaceutical Congresses.